Tool overview
Anumana is listed under Healthcare AI tools.
What is Anumana?
Anumana develops clinically validated ECG-AI algorithms that analyze standard 12-lead electrocardiograms to support earlier cardiovascular detection. Its commercially available ECG-AI LEF software aids clinicians in identifying low left ventricular ejection fraction and integrates into approved healthcare workflows.
Best for
Healthcare providers adding regulated ECG AI to cardiac workflows
Who is it for?
Decision note
Accepted for Preview after independent V411 official-source research. Apply only after failures = 0, warnings = 0, unmapped = 0, and review of controlled fields, Arabic v2 parity, outreach, affiliate status, logo QA, rebrand handling, and explicit clears.
Key features
AI analysis of standard 12-lead ECGs
FDA-cleared ECG-AI LEF algorithm
Clinical workflow and ECG-system integration
Evidence library and regulated instructions
Use cases
Screening for low ejection fraction
Supporting earlier heart-failure evaluation
Adding AI insights to routine ECGs
Integrating cardiovascular AI in clinics
Pros
- Focused clinically validated use case
- FDA-cleared commercial algorithm
- Designed for existing ECG workflows
Limitations
ECG-AI LEF is not a stand-alone diagnostic or monitoring device and should be used jointly with clinician judgment. Positive and negative results require interpretation within the patient context, indications for use, regulatory status, and appropriate follow-up evaluation.
Pricing details
Billing options
Custom healthcare contract
Pricing note
Anumana directs healthcare organizations to contact the company for implementation and demonstrations. Public self-service pricing, an ongoing free plan, and a generally available free trial were not confirmed for the regulated clinical product.
Supported languages
- English
Integrations
Philips ECG-AI Marketplace
Please log in to join the discussion.